Page last updated: 2024-11-11

7-oxoprostaglandin i2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-oxoprostaglandin I2: stable prostacyclin mimic; structure given in first source; RN given refers to (5Z,9alpha,11alpha,13E,15S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438364
CHEMBL ID1206391
MeSH IDM0104447

Synonyms (8)

Synonym
7-oxoprostaglandin i2
(5z)-5-[(3ar,4r,5r,6as)-5-hydroxy-4-[(e,3s)-3-hydroxyoct-1-enyl]-3-oxo-4,5,6,6a-tetrahydro-3ah-cyclopenta[b]furan-2-ylidene]pentanoic acid
7-oxo-pgi2-na
7-ketoprostaglandin i(2)
79821-50-4
7-oxoprostacyclin
prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-7-oxo-, (5z,9alpha,11alpha,13e,15s)-
CHEMBL1206391

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" It was shown that (1) all tested compounds inhibited the number and severity of the intestinal mucosal lesions, however, to different extent; (2) the inhibition of the development of small intestinal mucosal damage displayed a dose-response relationship; (3) 17-aza-PGF2 alpha was found to have the most potent effect on the development of the intestinal lesions as well as on the development of gastric mucosal damage produced by ethanol."( Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
Beró, T; Garamszegi, M; Jávor, T; Mózsik, G, 1984
)
0.27
" administration of the drug in a dosage of 50 micrograms/kg."( The late effect of 7-oxo prostacyclin protects the rat heart against calcium paradox.
Ravingerová, T; Tribulová, N; Ziegelhöffer, A, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (45.83)18.7374
1990's12 (50.00)18.2507
2000's1 (4.17)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]